Cargando…

Comparative Recurrence Analysis of Pancreatic Adenocarcinoma after Resection

PURPOSE: The relation between tumor sites of pancreatic ductal adenocarcinoma (PDAC) and recurrence was not fully investigated before. We aimed to describe the differences of recurrent patterns in PDAC of head and body/tail after curative surgery. METHODS: The recurrent patterns of PDAC were compare...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Chaobin, Cai, Zhiyuan, Zhang, Yu, Lin, Xiaojun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553472/ https://www.ncbi.nlm.nih.gov/pubmed/34721578 http://dx.doi.org/10.1155/2021/3809095

Ejemplares similares

A Quantitative Clinicopathological Signature for Predicting Recurrence Risk of Pancreatic Ductal Adenocarcinoma After Radical Resection
por: He, Chaobin, et al.
Publicado: (2019)

Overall survival and cancer-specific survival in patients with surgically resected pancreatic head adenocarcinoma: A competing risk nomogram analysis
por: He, Chaobin, et al.
Publicado: (2018)

A Novel Nomogram to Predict Survival in Patients With Recurrence of Pancreatic Ductal Adenocarcinoma After Radical Resection
por: He, Chaobin, et al.
Publicado: (2020)

Effect of prior cancer on survival outcomes for patients with pancreatic adenocarcinoma: a propensity score analysis
por: He, Chaobin, et al.
Publicado: (2019)

Development and validation of a nomogram to predict liver metastasis in patients with pancreatic ductal adenocarcinoma: a large cohort study
por: He, Chaobin, et al.
Publicado: (2019)

Nomogram to Predict Cancer-Specific Survival in Patients with Pancreatic Acinar Cell Carcinoma: A Competing Risk Analysis
por: He, Chaobin, et al.
Publicado: (2018)

Prognostic Model to Predict Cancer-Specific Survival for Patients With Gallbladder Carcinoma After Surgery: A Population-Based Analysis
por: He, Chaobin, et al.
Publicado: (2019)

Competing risk analyses of overall survival and cancer-specific survival in patients with combined hepatocellular cholangiocarcinoma after surgery
por: He, Chaobin, et al.
Publicado: (2019)

Score for the Overall Survival Probability of Patients With Pancreatic Adenocarcinoma of the Body and Tail After Surgery: A Novel Nomogram-Based Risk Assessment
por: He, Chaobin, et al.
Publicado: (2020)

Comparison of combination therapies in the management of locally advanced pancreatic cancer: Induction chemotherapy followed by irreversible electroporation vs radiofrequency ablation
por: He, Chaobin, et al.
Publicado: (2020)

Comparison of Survival Between Irreversible Electroporation Followed by Chemotherapy and Chemotherapy Alone for Locally Advanced Pancreatic Cancer
por: He, Chaobin, et al.
Publicado: (2020)

Prediction of early recurrence of pancreatic ductal adenocarcinoma after resection
por: Sugawara, Toshitaka, et al.
Publicado: (2021)

An Inflammation-Index Signature Predicts Prognosis of Patients with Intrahepatic Cholangiocarcinoma After Curative Resection
por: He, Chaobin, et al.
Publicado: (2021)

The prognostic and predictive value of the combination of the neutrophil-to-lymphocyte ratio and the platelet-to-lymphocyte ratio in patients with hepatocellular carcinoma who receive transarterial chemoembolization therapy
por: He, Chaobin, et al.
Publicado: (2019)

Survival Comparison of Neoadjuvant Chemotherapy Followed by Irreversible Electroporation Versus Conversional Resection for Locally Advanced Pancreatic Cancer
por: He, Chaobin, et al.
Publicado: (2021)

Nomograms predict long-term survival for patients with periampullary adenocarcinoma after pancreatoduodenectomy
por: He, Chaobin, et al.
Publicado: (2018)

Analysis of preoperative risk factors for early recurrence after curative pancreatoduodenectomy for resectable pancreatic adenocarcinoma
por: Burasakarn, Pipit, et al.
Publicado: (2022)

CXCR4 Expression Predicts Early Liver Recurrence and Poor Survival After Resection of Pancreatic Adenocarcinoma
por: Liao, Wei-Chih, et al.
Publicado: (2012)

Survival Comparisons of Hepatic Arterial Infusion Chemotherapy With mFOLFOX and Transarterial Chemoembolization in Patients With Unresectable Intrahepatic Cholangiocarcinoma
por: Cai, Zhiyuan, et al.
Publicado: (2021)

T‐cell activation and immune memory enhancement induced by irreversible electroporation in pancreatic cancer
por: He, Chaobin, et al.
Publicado: (2020)

Plasma biomarkers for prediction of early tumor recurrence after resection of pancreatic ductal adenocarcinoma
por: Rittmann, Marie-Claire, et al.
Publicado: (2021)

Irreversible electroporation versus radiotherapy after induction chemotherapy on survival in patients with locally advanced pancreatic cancer: a propensity score analysis
por: He, Chaobin, et al.
Publicado: (2019)

Implantation of a neoantigen-targeted hydrogel vaccine prevents recurrence of pancreatic adenocarcinoma after incomplete resection
por: Delitto, Daniel, et al.
Publicado: (2021)

Successful resection of port site recurrence of pancreatic ductal adenocarcinoma after laparoscopic distal pancreatectomy
por: Aida, Takashi, et al.
Publicado: (2023)

Computed Tomography-Guided Cryoablation of Local Recurrence after Primary Resection of Pancreatic Adenocarcinoma
por: Pusceddu, Claudio, et al.
Publicado: (2015)

Utility of endoscopic ultrasound for assessment of locoregional recurrence of pancreatic adenocarcinoma after surgical resection
por: Ragheb, Jonathan G., et al.
Publicado: (2023)

Recurrence Patterns for Pancreatic Ductal Adenocarcinoma after Upfront Resection Versus Resection Following Neoadjuvant Therapy: A Comprehensive Meta-Analysis
por: Ratnayake, Bathiya, et al.
Publicado: (2020)

A Novel Prediction Tool Based on Large Cohorts to Determine the Cancer-Specific Survival Probability of Patients With Locally Advanced Pancreatic Cancer After Irreversible Electroporation Treatment
por: He, Chaobin, et al.
Publicado: (2020)

A feasible CT feature to differentiate focal‐type autoimmune pancreatitis from pancreatic ductal adenocarcinoma
por: He, Chaobin, et al.
Publicado: (2019)

Surgical Resection or Ablation for Recurrent Pancreatic Ductal Adenocarcinoma: An Analysis of Oncologic Outcomes According to the Recurrence Type
por: Lee, Boram, et al.
Publicado: (2021)

Palliative Resection of Pancreatic Adenocarcinoma
por: Johnson, C. D.
Publicado: (1995)

The systemic inflammation response index predicts survival and recurrence in patients with resectable pancreatic ductal adenocarcinoma
por: Li, Shuo, et al.
Publicado: (2019)

Circulating tumour cells as an indicator of early and systemic recurrence after surgical resection in pancreatic ductal adenocarcinoma
por: Park, Yejong, et al.
Publicado: (2021)

A Refined Staging Model for Resectable Pancreatic Ductal Adenocarcinoma Incorporating Examined Lymph Nodes, Location of Tumor and Positive Lymph Nodes Ratio
por: Song, Yunda, et al.
Publicado: (2018)

The impact of resection margin distance on survival and recurrence in pancreatic ductal adenocarcinoma in a retrospective cohort analysis
por: Obonyo, Dennis, et al.
Publicado: (2023)

Preoperative recurrence prediction in pancreatic ductal adenocarcinoma after radical resection using radiomics of diagnostic computed tomography
por: Li, Xiawei, et al.
Publicado: (2021)

Preoperative CEA levels are supplementary to CA19-9 levels in predicting prognosis in patients with resectable intrahepatic cholangiocarcinoma
por: He, Chaobin, et al.
Publicado: (2018)

Surgical management of periampullary adenocarcinoma: defining an optimal prognostic lymph node stratification schema
por: He, Chaobin, et al.
Publicado: (2018)

Increased Overall Survival and Decreased Cancer-Specific Mortality in Patients with Hepatocellular Carcinoma Treated by Transarterial Chemoembolization and Human Adenovirus Type-5 Combination Therapy: a Competing Risk Analysis
por: He, Chaobin, et al.
Publicado: (2018)

Comparative effectiveness of primary tumor resection in patients with stage III pancreatic adenocarcinoma
por: Sun, Ke, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_1ju601528b2b8k9fqp6jlg4en5